Absci (ABSI) Capital Leases (2020 - 2024)

Absci (ABSI) reported Capital Leases of $6000.0 for Q2 2024, down 97.56% on a YoY basis from $246000.0 in Q3 2023, and down 79.31% sequentially from $29000.0 in Q1 2024.

Absci (ABSI) Capital Leases (2020 - 2024) Analysis & Trends

Absci (ABSI) has 5 years of Capital Leases data on file, last reported at $6000.0 in Q2 2024.

  • For the quarter ending Q2 2024, Capital Leases fell 97.56% year-over-year to $6000.0; the trailing twelve-month figure through Jun 2024 stood at $6000.0 (down 97.56% YoY), and the FY2023 full-year result was $76000.0, down 89.87% from the prior year.
  • Capital Leases eased to $6000.0 in Q2 2024, from $29000.0 in the prior quarter.
  • In the past five years, Capital Leases ranged from a high of $4.0 million in Q3 2021 to a low of $6000.0 in Q2 2024.
  • A 5-year average of $1.5 million and a median of $1.0 million in 2022 frame the typical range for Capital Leases.
  • Across the five-year window, Capital Leases increased 16.81% in 2021 and sank 97.56% in 2024, its largest moves.
  • Tracing ABSI's Capital Leases over 5 years: stood at $2.8 million in 2020, then gained by 16.81% to $3.2 million in 2021, then slumped by 76.79% to $750000.0 in 2022, then sank by 89.87% to $76000.0 in 2023, then sank by 92.11% to $6000.0 in 2024.
  • Business Quant data shows ABSI's Capital Leases at $6000.0 in Q2 2024, $29000.0 in Q1 2024, and $76000.0 in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Absci 1.23 Bn 1.11 Bn -

Historic Data

Download Data
DateValue
Jun 30, 2024 6,000.00
Mar 31, 2024 29,000.00
Dec 31, 2023 76,000.00
Sep 30, 2023 162,000.00
Jun 30, 2023 246,000.00
Mar 31, 2023 347,000.00
Dec 31, 2022 750,000.00
Sep 30, 2022 1.26 Mn
Jun 30, 2022 1.82 Mn
Mar 31, 2022 2.40 Mn
Dec 31, 2021 3.23 Mn
Sep 30, 2021 4.01 Mn
Jun 30, 2021 3.20 Mn
Dec 31, 2020 2.77 Mn